Skip to main content

Table 4 Non-recurrent vs. recurrent patients in the larger-tumor group (n = 22)

From: Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

 All 22 patientsNon-recurrent (n = 13)Recurrent (n = 9)p value
Tumor diameter27.0, 23.0–34.026.0, 22.0–33.028.0, 26.0–35.00.331
FDG SUVmax8.59, 6.17–11.86.98, 5.38–9.799.73, 8.46–13.210.015
FDG MTV8.06, 5.09–10.426.60, 1.89–9.158.09, 3.52–10.80.973
FMISO SUVmax1.70, 1.41–2.321.42, 0.94–1.672.21, 1.90–2.740.002
FMISO TMR1.45, 1.05–1.941.07, 0.72–1.542.22, 1.79–2.440.001
FMISO TBR1.13, 0.81–1.490.91, 0.63–1.121.70, 1.37–1.800.002
  1. Abbreviations are explained in Table 2 footnote